ALLMedicine™ Diabetic Nephropathy Center
Research & Reviews 8,825 results
https://doi.org/10.1515/jbcpp-2020-0099
Journal of Basic and Clinical Physiology and Pharmacology; Rind L, Ahmad M et. al.
Feb 27th, 2021 - N-acetylcysteine (NAC) is considered as the body's major antioxidant molecules with diverse biological properties. In this review, the pharmacokinetics, safety and efficacy report on both the preclinical and clinical summary of NAC is discussed. B...
https://doi.org/10.1016/j.taap.2021.115465
Toxicology and Applied Pharmacology; Yang X, Luo W et. al.
Feb 25th, 2021 - Diabetic nephropathy (DN) is a chronic inflammatory renal disease induced by hyperglycemia. Recent studies have implicated cyclin-dependent kinase 9 (CDK9) in inflammatory responses and renal fibrosis. In this study, we explored a potential role o...
https://doi.org/10.1016/j.gene.2021.145532
Gene Li KX, Ji MJ et. al.
Feb 25th, 2021 - As one of the most common complications of diabetes, nephropathy develops in approximately 40% of diabetic individuals. Although end stage kidney disease is known as one of the most consequences of diabetic nephropathy, the majority of diabetic in...
https://doi.org/10.1186/s12882-021-02271-8 10.1016/S0140-6736(14)61601-9 10.1056/NEJMoa0806359 10.1681/ASN.2012070718 10.1159/000168653 10.1016/j.bbrc.2010.10.012 10.1007/s11010-019-03535-6 10.1016/S0140-6736(78)91505-2 10.1016/S0140-6736(07)60527-3 10.1161/01.CIR.102.22.2677 10.1172/JCI13210 10.1016/j.atherosclerosis.2013.09.023 10.1253/circj.CJ-11-0941 10.1161/CIRCULATIONAHA.114.011590 10.1136/gutjnl-2017-313778 10.2337/dc07-0931 10.1161/CIR.0000000000000510 10.1186/1475-2840-12-21 10.1007/s10157-013-0879-4 10.2337/dc10-1303 10.1017/S1368980011000504 10.1210/jcem-66-4-678 10.1007/BF00505658 10.1016/S0090-6980(98)00066-5 10.1016/j.yexcr.2007.03.036 10.1159/000183217 10.1161/CIRCHEARTFAILURE.116.003291 10.18632/oncotarget.25005 10.1016/j.cmet.2017.01.004 10.2337/diabetes.51.10.3090 10.1681/ASN.2014040350
BMC Nephrology; Okamura T, Nakajima H et. al.
Feb 24th, 2021 - Diabetic nephropathy, a major complication of diabetes, is the primary risk factor for dialysis, cardiovascular diseases, and mortality. Dietary fatty acids (FAs) have been revealed to be related with cardiovascular diseases in the general populat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896734
Drug Design, Development and Therapy; Guo L, Jiang B et. al.
Feb 24th, 2021 - Diabetic Nephropathy remains a major cause of morbidity and mortality in patients suffering from renal dysfunction. This study accessed the nephroprotective role of Adropinin against streptozotocin (STZ) induced diabetic nephropathy in rats and sc...
Guidelines 2 results
https://doi.org/10.1016/j.diabres.2018.11.008
Diabetes Research and Clinical Practice; Liu XM, Dong ZY et. al.
Nov 25th, 2018 - Diabetes mellitus (DM) has overtaken infection and immunological factors as the most common cause of end-stage renal disease. The 2007 Kidney Disease Outcomes Quality Initiative (KDOQI) guideline is a widely accepted guideline for the clinical dia...
https://doi.org/10.1111/dme.13676
Diabetic Medicine : a Journal of the British Diabetic Ass... Frankel AH, Kazempour-Ardebili S et. al.
Aug 28th, 2018 - Diabetic nephropathy remains the principal cause of end-stage renal failure in the UK and its prevalence is set to increase. People with diabetes and end-stage renal failure on maintenance haemodialysis are highly vulnerable, with complex comorbid...
Drugs 551 results see all →
Clinicaltrials.gov 9,513 results
https://doi.org/10.1515/jbcpp-2020-0099
Journal of Basic and Clinical Physiology and Pharmacology; Rind L, Ahmad M et. al.
Feb 27th, 2021 - N-acetylcysteine (NAC) is considered as the body's major antioxidant molecules with diverse biological properties. In this review, the pharmacokinetics, safety and efficacy report on both the preclinical and clinical summary of NAC is discussed. B...
https://doi.org/10.1016/j.taap.2021.115465
Toxicology and Applied Pharmacology; Yang X, Luo W et. al.
Feb 25th, 2021 - Diabetic nephropathy (DN) is a chronic inflammatory renal disease induced by hyperglycemia. Recent studies have implicated cyclin-dependent kinase 9 (CDK9) in inflammatory responses and renal fibrosis. In this study, we explored a potential role o...
https://doi.org/10.1016/j.gene.2021.145532
Gene Li KX, Ji MJ et. al.
Feb 25th, 2021 - As one of the most common complications of diabetes, nephropathy develops in approximately 40% of diabetic individuals. Although end stage kidney disease is known as one of the most consequences of diabetic nephropathy, the majority of diabetic in...
https://doi.org/10.1186/s12882-021-02271-8 10.1016/S0140-6736(14)61601-9 10.1056/NEJMoa0806359 10.1681/ASN.2012070718 10.1159/000168653 10.1016/j.bbrc.2010.10.012 10.1007/s11010-019-03535-6 10.1016/S0140-6736(78)91505-2 10.1016/S0140-6736(07)60527-3 10.1161/01.CIR.102.22.2677 10.1172/JCI13210 10.1016/j.atherosclerosis.2013.09.023 10.1253/circj.CJ-11-0941 10.1161/CIRCULATIONAHA.114.011590 10.1136/gutjnl-2017-313778 10.2337/dc07-0931 10.1161/CIR.0000000000000510 10.1186/1475-2840-12-21 10.1007/s10157-013-0879-4 10.2337/dc10-1303 10.1017/S1368980011000504 10.1210/jcem-66-4-678 10.1007/BF00505658 10.1016/S0090-6980(98)00066-5 10.1016/j.yexcr.2007.03.036 10.1159/000183217 10.1161/CIRCHEARTFAILURE.116.003291 10.18632/oncotarget.25005 10.1016/j.cmet.2017.01.004 10.2337/diabetes.51.10.3090 10.1681/ASN.2014040350
BMC Nephrology; Okamura T, Nakajima H et. al.
Feb 24th, 2021 - Diabetic nephropathy, a major complication of diabetes, is the primary risk factor for dialysis, cardiovascular diseases, and mortality. Dietary fatty acids (FAs) have been revealed to be related with cardiovascular diseases in the general populat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896734
Drug Design, Development and Therapy; Guo L, Jiang B et. al.
Feb 24th, 2021 - Diabetic Nephropathy remains a major cause of morbidity and mortality in patients suffering from renal dysfunction. This study accessed the nephroprotective role of Adropinin against streptozotocin (STZ) induced diabetic nephropathy in rats and sc...
News 177 results
https://www.medscape.com/viewarticle/944379
Jan 21st, 2021 - Takeaway Dapagliflozin lowers the risks of major adverse kidney and cardiovascular (CV) events and all-cause mortality in patients with chronic kidney disease (CKD), regardless of type 2 diabetes (T2D) status. These benefits also extend to patient...
https://www.staging.medscape.com/viewarticle/935505
Aug 10th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A new Canadian study has found increased expression of angiotensin-converting enzyme 2 (ACE2) receptors in the kidneys of patients with diabetic n...
https://www.medscape.com/viewarticle/935505
Aug 10th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A new Canadian study has found increased expression of angiotensin-converting enzyme 2 (ACE2) receptors in the kidneys of patients with diabetic n...
https://reference.medscape.com/viewarticle/926147_3
Apr 23rd, 2020 - Answer 2/5 Which of the following statements about diabetic nephropathy is accurate? Your peers chose: The rate of diabetic nephropathy progressively increases in individuals who have had diabetes for more than 20 years 0% Diabetic nephropathy fre...
https://reference.medscape.com/viewarticle/926149_1
Apr 23rd, 2020 - Diabetes is a growing global public health epidemic. According to data from the International Diabetes Federation, there were more than 450 million individuals worldwide with diabetes in 2017; by 2045, that number is expected to increase to 693 mi...